Table 4 Validity of the clusters for system summary (SS) and baseline (BL)
From: Clustering cliques for graph-based summarization of the biomedical research literature
Topic | Cohesion | Separation | Overall Validity | |||
|---|---|---|---|---|---|---|
SS | BL | SS | BL | SS | BL | |
Diabetes Mellitus | 0.38 | 0.41 | 0.70 | 0.22 | 0.46 | 0.29 |
(95% CI) | (0.32-0.45) | (0.35-0.48) | (0.64-0.76) | (0.17-0.28) | (0.43-0.56) | (0.23-0.35) |
Lung Neoplasms | 0.46 | 0.51 | 0.51 | 0.22 | 0.48 | 0.31 |
(95% CI) | (0.34-0.57) | (0.40-0.62) | (0.39-0.63) | (0.13-0.31) | (0.36-0.60) | (0.20-0.40) |
Schizophrenia | 0.81 | 0.86 | 0.91 | 0.35 | 0.86 | 0.50 |
(95% CI) | (0.70-0.92) | (0.76-0.96) | (0.84-0.99) | (0.22-0.48) | (0.76-0.96) | (0.36-0.64) |
Hypersensitivity | 0.46 | 0.54 | 0.38 | 0.23 | 0.42 | 0.32 |
(95% CI) | (0.37-0.54) | (0.46-0.63) | (0.30-0.46) | (0.16-0.30) | (0.33-0.50) | (0.24-0.40) |
Oxidative stress | 0.39 | 0.52 | 0.35 | 0.18 | 0.37 | 0.27 |
(95% CI) | (0.32-0.46) | (0.45-0.58) | (0.28-0.41) | (0.13-0.23) | (0.30-0.43) | (0.21-0.32) |
Hydrocortisone | 0.54 | 0.54 | 0.59 | 0.59 | 0.56 | 0.56 |
(95% CI) | (0.47-0.62) | (0.50-0.58) | (0.51-0.66) | (0.55-0.63) | (0.49-0.64) | (0.52-0.60) |
Heat-Shock Proteins | 0.54 | 0.54 | 0.24 | 0.16 | 0.33 | 0.25 |
(95% CI) | (0.47-0.60) | (0.47-0.60) | (0.19-0.30) | (0.11-0.20) | (0.27-0.40) | (0.19-0.29) |
Anti-inflammatory Agents, Non-steroidal | 0.49 | 0.48 | 0.71 | 0.43 | 0.58 | 0.45 |
(95% CI) | (0.42-0.56) | (0.41-0.55) | (0.64-0.77) | (0.37-0.50) | (0.51-0.65) | (0.38-0.52) |
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 0.38 | 0.43 | 0.35 | 0.24 | 0.36 | 0.31 |
(95% CI) | (0.31-0.45) | (0.36-0.50) | (0.28-0.42) | (0.18-0.29) | (0.29-0.43) | (0.24-0.37) |
Tumor Necrosis Factors | 0.53 | 0.51 | 0.31 | 0.54 | 0.39 | 0.52 |
(95% CI) | (0.45-0.61) | (0.42-0.60) | (0.23-0.38) | (0.46-0.63) | (0.31-0.47) | (0.44-0.61) |
Overall | 0.47 | 0.51 | 0.40 | 0.24 | 0.43 | 0.33 |
(95% CI) | (0.45-0.50) | (0.49-0.54) | (0.38-0.42) | (0.22-0.26) | (0.41-0.46) | (0.31-0.35) |